{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:33:43Z","timestamp":1770338023658,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["57668"],"award-info":[{"award-number":["57668"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95356-5","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:35:58Z","timestamp":1748860558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival outcomes in secondary and primary acute lymphoblastic leukemia: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Fatemeh","family":"Abedini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirreza","family":"Manteghinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Rezaeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeedeh","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Samankan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Khalvandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehran","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"7","key":"95356_CR1","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/ijerph9072444","volume":"9","author":"S Ezoe","year":"2012","unstructured":"Ezoe, S. Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int. J. Environ. Res. Public Health 9(7), 2444\u20132453 (2012).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"95356_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nrc722","volume":"2","author":"S Bhatia","year":"2002","unstructured":"Bhatia, S. & Sklar, C. Second cancers in survivors of childhood cancer. Nat. Rev. Cancer 2(2), 124\u2013132 (2002).","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"95356_CR3","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/sj.leu.2404885","volume":"21","author":"C Hartford","year":"2007","unstructured":"Hartford, C. et al. Genome scan implicates adhesion biological pathways in secondary leukemia. Leukemia 21(10), 2128\u20132136 (2007).","journal-title":"Leukemia"},{"issue":"24","key":"95356_CR4","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","volume":"325","author":"C-H Pui","year":"1991","unstructured":"Pui, C.-H. et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N. Engl. J. Med. 325(24), 1682\u20131687 (1991).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"95356_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/gcc.10040","volume":"33","author":"JD Rowley","year":"2002","unstructured":"Rowley, J. D. & Olney, H. J. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosom. Cancer 33(4), 331\u2013345 (2002).","journal-title":"Genes Chromosom. Cancer"},{"issue":"15","key":"95356_CR6","first-page":"1591","volume":"352","author":"J Pedersen-Bjergaard","year":"2005","unstructured":"Pedersen-Bjergaard, J. Insights into leukemogenesis from therapy-related leukemia. Mass Med. Soc. 352(15), 1591\u20131594 (2005).","journal-title":"Mass Med. Soc."},{"issue":"3","key":"95356_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 98(3), 502\u2013526 (2023).","journal-title":"Am. J. Hematol."},{"issue":"20","key":"95356_CR8","first-page":"2391","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, J. Am. Soc. Hematol. 127(20), 2391\u20132405 (2016).","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"31","key":"95356_CR9","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","volume":"33","author":"LS Granfeldt \u00d8stg\u00e5rd","year":"2015","unstructured":"Granfeldt \u00d8stg\u00e5rd, L. S. et al. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study. J Clin Oncol. 33(31), 3641\u20133649 (2015).","journal-title":"J Clin Oncol."},{"issue":"20","key":"95356_CR10","first-page":"4140","volume":"5","author":"A Patel","year":"2021","unstructured":"Patel, A. et al. Therapy-Related Myeloid Neoplasms in 109 Patients Following Radiation Monotherapy. Blood Adv. 5(20), 4140\u20134148 (2021).","journal-title":"Blood Adv."},{"issue":"7","key":"95356_CR11","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","volume":"117","author":"S Kayser","year":"2011","unstructured":"Kayser, S. et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood 117(7), 2137\u20132145 (2011).","journal-title":"Blood"},{"issue":"1","key":"95356_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","volume":"102","author":"SM Smith","year":"2003","unstructured":"Smith, S. M. et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 102(1), 43\u201352 (2003).","journal-title":"Blood"},{"issue":"1","key":"95356_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjh.13386","volume":"170","author":"C Ganzel","year":"2015","unstructured":"Ganzel, C. et al. Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy. Br. J. Haematol. 170(1), 50\u201355 (2015).","journal-title":"Br. J. Haematol."},{"issue":"3","key":"95356_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/PAP.0b013e31821698ef","volume":"18","author":"A Bagg","year":"2011","unstructured":"Bagg, A. Therapy-associated lymphoid proliferations. Adv. Anat. Pathol. 18(3), 199\u2013205 (2011).","journal-title":"Adv. Anat. Pathol."},{"issue":"10","key":"95356_CR15","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3324\/haematol.2018.193599","volume":"103","author":"I Aldoss","year":"2018","unstructured":"Aldoss, I. et al. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients. Haematologica 103(10), 1662 (2018).","journal-title":"Haematologica"},{"issue":"5","key":"95356_CR16","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/bmt.2015.8","volume":"50","author":"I Aldoss","year":"2015","unstructured":"Aldoss, I., Dagis, A., Palmer, J., Forman, S. & Pullarkat, V. Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome. Bone Marrow Transplant. 50(5), 746\u2013748 (2015).","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"95356_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/10428194.2015.1040013","volume":"57","author":"N Kelleher","year":"2016","unstructured":"Kelleher, N. et al. Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy. Leuk. Lymphoma 57(1), 86\u201391 (2016).","journal-title":"Leuk. Lymphoma"},{"issue":"10230","key":"95356_CR18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard, F. & Mohty, M. Acute lymphoblastic leukaemia. Lancet (London, England). 395(10230), 1146\u20131162 (2020).","journal-title":"Lancet (London, England)."},{"issue":"19","key":"95356_CR19","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","volume":"130","author":"SK Tasian","year":"2017","unstructured":"Tasian, S. K., Loh, M. L. & Hunger, S. P. Philadelphia chromosome-like acute lymphoblastic leukemia. Blood 130(19), 2064\u20132072 (2017).","journal-title":"Blood"},{"issue":"40","key":"95356_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1200\/EDBK_280175","volume":"40","author":"DJ DeAngelo","year":"2020","unstructured":"DeAngelo, D. J., Jabbour, E. & Advani, A. Recent Advances in Managing Acute Lymphoblastic Leukemia. Am Soc. Clin. Oncol. Educ. Book. 40(40), 330\u2013342 (2020).","journal-title":"Am Soc. Clin. Oncol. Educ. Book."},{"issue":"12","key":"95356_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243657","volume":"15","author":"W Zhang","year":"2020","unstructured":"Zhang, W., Kuang, P. & Liu, T. Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis. PLoS ONE 15(12), e0243657 (2020).","journal-title":"PLoS ONE"},{"issue":"4","key":"95356_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ng.3230","volume":"47","author":"AK Andersson","year":"2015","unstructured":"Andersson, A. K. et al. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat. Genet. 47(4), 330\u2013337 (2015).","journal-title":"Nat. Genet."},{"key":"95356_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2017.00004","volume":"5","author":"AC Winters","year":"2017","unstructured":"Winters, A. C. & Bernt, K. M. MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches. Front Pediatr. 5, 4 (2017).","journal-title":"Front Pediatr."},{"issue":"1","key":"95356_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40364-015-0029-0","volume":"3","author":"CA Tirado","year":"2015","unstructured":"Tirado, C. A. et al. A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature. Biomarker Res. 3(1), 4 (2015).","journal-title":"Biomarker Res."},{"issue":"2","key":"95356_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41408-021-00416-4","volume":"11","author":"BA Pitel","year":"2021","unstructured":"Pitel, B. A. et al. Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis. Blood Cancer J. 11(2), 18 (2021).","journal-title":"Blood Cancer J."},{"issue":"4","key":"95356_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1182\/blood-2016-10-743765","volume":"129","author":"S Safavi","year":"2017","unstructured":"Safavi, S. & Paulsson, K. Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis. Blood 129(4), 420\u2013423 (2017).","journal-title":"Blood"},{"issue":"24","key":"95356_CR27","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1182\/bloodadvances.2019000925","volume":"3","author":"C Saygin","year":"2019","unstructured":"Saygin, C. et al. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes. Blood Adv. 3(24), 4228\u20134237 (2019).","journal-title":"Blood Adv."},{"issue":"7","key":"95356_CR28","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1038\/s41375-020-01061-9","volume":"35","author":"L Barnea Slonim","year":"2021","unstructured":"Barnea Slonim, L. et al. Therapy-related B-cell acute lymphoblastic leukemia in adults has unique genetic profile with frequent loss of TP53 and inferior outcome. Leukemia 35(7), 2097\u20132101 (2021).","journal-title":"Leukemia"},{"issue":"4","key":"95356_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/bjh.17906","volume":"196","author":"ZH Abdel Rahman","year":"2022","unstructured":"Abdel Rahman, Z. H. et al. Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia. Br. J. Haematol. 196(4), 963\u2013968 (2022).","journal-title":"Br. J. Haematol."},{"issue":"6","key":"95356_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3324\/haematol.2011.057752","volume":"97","author":"G Tang","year":"2012","unstructured":"Tang, G. et al. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?. Haematologica 97(6), 919 (2012).","journal-title":"Haematologica"},{"key":"95356_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.leukres.2018.07.024","volume":"72","author":"F Ferraro","year":"2018","unstructured":"Ferraro, F. et al. Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data. Leuk. Res. 72, 86\u201391 (2018).","journal-title":"Leuk. Res."},{"key":"95356_CR32","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.1 ed: Cochrane; 2020.","DOI":"10.1002\/9781119536604"},{"key":"95356_CR33","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clini Res Ed). 372, n71 (2021).","journal-title":"BMJ (Clini Res Ed)."},{"key":"95356_CR34","unstructured":"Rohatgi A. WebPlotDigitizer California, USA [updated September, 2022. 4.6:[Available from: https:\/\/automeris.io\/WebPlotDigitizer."},{"issue":"1","key":"95356_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S. & Sydes, M. R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8(1), 16 (2007).","journal-title":"Trials"},{"key":"95356_CR36","volume-title":"JBI Manual for Evidence Synthesis JBI","author":"S Moola","year":"2020","unstructured":"Moola, S. et al. Systematic reviews of etiology and risk. In JBI Manual for Evidence Synthesis JBI (ed. Aromataris, E. M. Z.) (2020)."},{"issue":"4","key":"95356_CR37","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg, C. B. & Mazumdar, M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics 50(4), 1088\u20131101 (1994).","journal-title":"Biometrics"},{"issue":"7109","key":"95356_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clini. Res. Ed). 315(7109), 629 (1997).","journal-title":"BMJ (Clini. Res. Ed)."},{"issue":"449","key":"95356_CR39","first-page":"89","volume":"95","author":"S Duval","year":"2000","unstructured":"Duval, S. & Tweedie, R. A Nonparametric, \u201cTrim and Fill\u201d Method of Accounting for Publication Bias in Meta-Analysis. J. Am. Stat. Assoc. 95(449), 89\u201398 (2000).","journal-title":"J. Am. Stat. Assoc."},{"issue":"2","key":"95356_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval, S. & Tweedie, R. Trim and Fill: A Simple Funnel-Plot\u2013Based Method of Testing and Adjusting for Publication Bias in Meta-Analysis. Biometrics 56(2), 455\u2013463 (2000).","journal-title":"Biometrics"},{"issue":"9","key":"95356_CR41","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1016\/j.clml.2020.04.013","volume":"20","author":"J Zhong","year":"2020","unstructured":"Zhong, J., Yu, X. & Zhang, X. Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different Ages. Clin. Lymphoma Myeloma Leuk. 20(9), e622\u2013e627 (2020).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"9","key":"95356_CR42","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1038\/bcj.2017.81","volume":"7","author":"AS Rosenberg","year":"2017","unstructured":"Rosenberg, A. S. et al. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J. 7(9), e605 (2017).","journal-title":"Blood Cancer J."},{"issue":"12","key":"95356_CR43","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.leukres.2015.09.011","volume":"39","author":"S Giri","year":"2015","unstructured":"Giri, S. et al. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis. Leuk Res. 39(12), 1342\u20131346 (2015).","journal-title":"Leuk Res."},{"issue":"2","key":"95356_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/cam4.1266","volume":"7","author":"A Swaika","year":"2018","unstructured":"Swaika, A. et al. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes. Cancer Med. 7(2), 499\u2013507 (2018).","journal-title":"Cancer Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95356-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:02:24Z","timestamp":1748865744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95356-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95356"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95356-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of Isfahan University of Medical Science. (Ethics Code: IR.ARI.MUI.REC.1401.104).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"19282"}}